Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Eric A. Goethe, Benjamin Deneen, Jeffrey Noebels & Ganesh Rao. (2023) The Role of Hyperexcitability in Gliomagenesis. International Journal of Molecular Sciences 24:1, pages 749.
Crossref
Crossref
Kavitha Godugu, Bruce A Hay, Gennadi V Glinsky & Shaker A Mousa. (2023) Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme. Neuro-Oncology Advances 5:1.
Crossref
Crossref
Morteza Kamali, Thomas J. Webster, Amir Amani, Mahmoud Reza Hadjighassem, Mohammad Reza Malekpour, Fatemeh Tirgar, Masood Khosravani & Mahdi Adabi. (2023) Effect of folate-targeted Erlotinib loaded human serum albumin nanoparticles on tumor size and survival rate in a rat model of glioblastoma. Life Sciences 313, pages 121248.
Crossref
Crossref
Zhen Wang, Yuyang Liu, Yong Xiao, Yandong Xie, Ran Wang, Yiding Zhang, Qi Zhou, Liang Liu, Shuo Sun, Hong Xiao, Yuanjie Zou, Kun Yang, Xiang Li, Mengjie Zhao, Yifang Hu & Hongyi Liu. (2022) Intelligent Nanoparticles With pH-Sensitive Co-Delivery of Temozolomide and siEGFR to Ameliorate Glioma Therapy. Frontiers in Genetics 13.
Crossref
Crossref
Qingfa Tang, Haihong Cao, Ni Tong, Yuanliang Liu, Wanyu Wang, Yuheng Zou, Lanyang Xu, Zhiyun Zeng, Wei Xu, Zhixin Yin, Wenjuan Ma & Qirui Wang. (2022) Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway. Phytomedicine 99, pages 154016.
Crossref
Crossref
Carmen Sze-Ching Lo, Karrie Mei-Yee Kiang & Gilberto Ka-Kit Leung. (2022) Anti-tumor effects of vitamin D in glioblastoma: mechanism and therapeutic implications. Laboratory Investigation 102:2, pages 118-125.
Crossref
Crossref
Emanuela B. Pucko & Robert P. Ostrowski. (2022) Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms. Pharmaceutics 14:2, pages 331.
Crossref
Crossref
Julián Henao-Restrepo, Yudys Anggelly Caro-Urrego, Lina Marcela Barrera-Arenas, Juan Carlos Arango-Viana & Maria Bermudez-Munoz. (2021) Expression of activator proteins of SHH/GLI and PI3K/Akt/mTORC1 signaling pathways in human gliomas is associated with high grade tumors. Experimental and Molecular Pathology 122, pages 104673.
Crossref
Crossref
Mayra Colardo, Marco Segatto & Sabrina Di Bartolomeo. (2021) Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update. International Journal of Molecular Sciences 22:9, pages 4899.
Crossref
Crossref
Yaodong Chen, Jiamei Niu, Lulu Li, Zizhuo Li, Jian Jiang, Mingwei Zhu, Tianxiu Dong, Jiuwei Zhang, Chunying Shi, Peng Xu, Yu Lu, Yan Jiang, Pengfei Liu & Wu Chen. (2020) Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway. Life Sciences 258, pages 118158.
Crossref
Crossref
Zulfikar Azam, Wei Shao, Ho-keung Ng, Jing Wang, Zhong-ping Chen & Shing-shunTony To. (2020) Comprehensive RNAseq analysis reveals PIK3CD promotes glioblastoma tumorigenesis by mediating PI3K-Akt signaling pathway. Glioma 3:3, pages 135.
Crossref
Crossref
Huanwen Chen, John Kuhn, Kathleen R Lamborn, Lauren E Abrey, Lisa M DeAngelis, Frank Lieberman, H Ian Robins, Susan M Chang, W K Alfred Yung, Jan Drappatz, Minesh P Mehta, Victor A Levin, Kenneth Aldape, Janet E Dancey, John J Wright, Michael D Prados, Timothy F Cloughesy, Patrick Y Wen & Mark R Gilbert. (2020) Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02. Neuro-Oncology Advances 2:1.
Crossref
Crossref
Sarmistha Talukdar, Luni Emdad, Swadesh K. Das & Paul B. Fisher. 2020. Receptor Tyrosine Kinases. Receptor Tyrosine Kinases
161
188
.
Margherita Ciano, Giada Mantellato, Martin Connolly, Mark Paul-Clark, Saffron Willis-Owen, Miriam F. Moffatt, William O. C. M. Cookson, Jane A. Mitchell, Michael I. Polkey, Simon M. Hughes, Paul R. Kemp & S. Amanda Natanek. (2019) EGF receptor (EGFR) inhibition promotes a slow-twitch oxidative, over a fast-twitch, muscle phenotype. Scientific Reports 9:1.
Crossref
Crossref
Jordi Martinez-Quintanilla, Ivan Seah, Melissa Chua & Khalid Shah. (2019) Oncolytic viruses: overcoming translational challenges. Journal of Clinical Investigation 129:4, pages 1407-1418.
Crossref
Crossref
Gulten Tuncel & Rasime Kalkan. (2018) Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme. Medical Oncology 35:9.
Crossref
Crossref
María Julia Ferronato, Eliana Noelia Alonso, Débora Gisele Salomón, María Eugenia Fermento, Norberto Ariel Gandini, Mario Alfredo Quevedo, Evangelina Mascaró, Cristian Vitale, Yagamare Fall, María Marta Facchinetti & Alejandro Carlos Curino. (2018) Antitumoral effects of the alkynylphosphonate analogue of calcitriol EM1 on glioblastoma multiforme cells. The Journal of Steroid Biochemistry and Molecular Biology 178, pages 22-35.
Crossref
Crossref
Dimitry A. Chistiakov, Ivan V. Chekhonin & Vladimir P. Chekhonin. (2017) The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme. European Journal of Pharmacology 810, pages 70-82.
Crossref
Crossref
Manfred Westphal, Cecile L. Maire & Katrin Lamszus. (2017) EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise. CNS Drugs 31:9, pages 723-735.
Crossref
Crossref
Megan M. Marlow, Sumedh S. Shah, Eduardo A. Véliz, Michael E. Ivan & Regina M. Graham. (2016) Treatment of adult and pediatric high-grade gliomas with Withaferin A: antitumor mechanisms and future perspectives. Journal of Natural Medicines 71:1, pages 16-26.
Crossref
Crossref
Krittalak Chakrabandhu & Anne-Odile Hueber. (2016) Fas Versatile Signaling and Beyond: Pivotal Role of Tyrosine Phosphorylation in Context-Dependent Signaling and Diseases. Frontiers in Immunology 7.
Crossref
Crossref
Xiaoman Li, Changjing Wu, Nianci Chen, Huadi Gu, Allen Yen, Liu Cao, Enhua Wang & Liang Wang. (2016) PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget 7:22, pages 33440-33450.
Crossref
Crossref
Eduard H. Panosyan, Joseph L. Lasky, Henry J. Lin, Albert Lai, Yang Hai, Xiuqing Guo, Michael Quinn, Stanley F. Nelson, Timothy F. Cloughesy & P. Leia Nghiemphu. (2016) Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids. Journal of Neuro-Oncology 128:1, pages 57-66.
Crossref
Crossref
Francisco Azuaje, Katja Tiemann & Simone P Niclou. (2015) Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma. Cell Communication and Signaling 13:1.
Crossref
Crossref
Hátylas Azevedo & Carlos Alberto Moreira-Filho. (2015) Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma. Scientific Reports 5:1.
Crossref
Crossref
Ran Xu, Chao Shang, Jungang Zhao, Yun Han, Jun Liu, Kuanbing Chen & Wenjun Shi. (2015) Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway. Tumor Biology 36:6, pages 4091-4100.
Crossref
Crossref
M. K. Petri, A. Brobeil, J. Planz, A. Bräuninger, S. Gattenlöhner, U. Nestler, A. Stenzinger, A. Paradowska & M. Wimmer. (2015) PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor. Journal of Neuro-Oncology 123:1, pages 15-25.
Crossref
Crossref
Clovis O Da Fonseca, Igor Petrone Soares, Daniele Sousa Clemençon, Sheila Rochlin, Leon Cardeman & Thereza Quirico-Santos. (2015) Perillyl alcohol inhalation concomitant with oral temozolomide halts progression of recurrent inoperable glioblastoma: a case report. Journal of Histology and Histopathology 2:1, pages 12.
Crossref
Crossref
Sharmistha Pal, Yingtao Bi, Luke Macyszyn, Louise C. Showe, Donald M. O'Rourke & Ramana V. Davuluri. (2014) Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes. Nucleic Acids Research 42:8, pages e64-e64.
Crossref
Crossref
Ryan Grant, Luis Kolb & Jennifer Moliterno. (2014) Molecular and genetic pathways in gliomas: the future of personalized therapeutics. CNS Oncology 3:2, pages 123-136.
Crossref
Crossref
Jie Zheng, Wei Du, Lai-jun Song, Rui Zhang, Lai-guang Sun, Feng-guo Chen & Xin-ting Wei. (2014) Norcantharidin induces growth inhibition and apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway. World Journal of Surgical Oncology 12:1, pages 207.
Crossref
Crossref